Internal Server Error

About LH Ventures

LH Ventures is a venture capital firm founded in 2009. It is primarily based out of San Marino, United States. It primarily invests in United States based startups. Its investments are spread across a wide range of sectors from High Tech to Life Sciences and Enterprise Applications. Overall, LH Ventures portfolio has seen 1 IPO and 6 acquisitions including key companies like Savara Pharma, Parcelpending and DePuy Synthes. LH Ventures has team of 1 people including 1 partners.
Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Portfolio IPOs
Portfolio Acquisitions
Portfolio Soonicorns

LH Ventures' List of Top Investments

LH Ventures has a portfolio of 24 companies. Their most notable investments include ParentSquare and Savara Pharma.Their portfolio spans across United States and Montenegro. They have invested in High Tech, Life Sciences, Enterprise Applications and 18 other sectors. Here is the list of top investments by LH Ventures:
Provider of app-based parent-teacher communication solutions. The platform engages every parent with automated email, text & app alerts, and language translation. School administrators take well-informed steps in consent with parents to improve child growth. Its app is available for Android and iOS devices.

Key facts about ParentSquare

  • Founded Year: 2011
  • Location: Santa Barbara (United States)
  • Stage: Seed
  • Total Funding till date: $12M
  • Employee Count: 403 as on Sep 30, 2026
  • Investors: LH Ventures, Jenkins Fund and 5 Others
  • Latest Funding Round: Seed, Sep 07, 2021, $*****
  • Highlight: Editors' Pick
Developer of therapeutics for rare respiratory diseases. The company’s lead product is molgramostim nebulizer solution, which is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) for autoimmune pulmonary alveolar proteinosis (aPAP).

Key facts about Savara Pharma

  • Founded Year: 2008
  • Location: Austin (United States)
  • Annual Revenue: $0 - $1M as on Dec 31, 2020
  • Stage: Public
  • Total Funding till date: $67.8M
  • Employee Count: 128 as on Sep 30, 2026
  • Investors: Bain Capital Life Sciences, Logos and 20 Others
  • Latest Funding Round: Post IPO, Dec 20, 2019, $*****
  • Highlight: Public
Developer of software for managing childcare business operations and classrooms. This platform provides tools for enrollment, billing, staff scheduling, and attendance tracking. It includes features for lesson planning, student progress monitoring, and communication between educators and families. The system supports administrative tasks and classroom management for early childhood and school-age programs.

Key facts about Kangarootime

Provider of electronic parcel storage lockers. The company installs electronic lockers in residential buildings which are then used to collect parcels on resident's behalf. Users can shop online and use normal residential address for package delivery. When the delivery company employee scans the package, a door automatically opens and stores the package. Users can later use the app to generate a password which can be entered in the kiosk to retrieve the package at a time of convenience of the user.

Key facts about Parcelpending

  • Founded Year: 2013
  • Location: Irvine (United States)
  • Stage: Acquired
  • Total Funding till date: $1.3M
  • Employee Count: 159 as on Sep 30, 2026
  • Investors: LH Ventures and Tech Coast Angels
  • Latest Funding Round: Series A, Jul 09, 2014, $*****
  • Highlight: Acquired
DePuy is a franchise of orthopaedic and neurosurgery companies. Acquired by Johnson & Johnson in 1998, its companies form part of the Johnson & Johnson Medical Devices group. DePuy develops and markets products under theCodman, DePuy Mitek, DePuy Orthopaedics and DePuy Spine brands. and for repairing and reconstructing traumatic skeletal injuries.DePuy Spine products facilitate fusion of the spine and correction of spinal deformities, preserving motion of the spine and repairing bone fractures.Codman products provide for the surgical treatment of neurological and central nervous system disorders through products such as hydrocephalic shunt valve systems, implantable drug pumps and micro-surgical instrumentations.DePuy Mitek products offer devices in sports medicine for the treatment of soft tissue injuries. On June 14, 2012, Johnson and Johnson completed the acquisition of Synthes, which was integrated with the DePuy franchise to establish the DePuy Synthes Companies of Johnson & Johnson

Key facts about DePuy Synthes

  • Founded Year: 1895
  • Location: Raynham (United States)
  • Stage: Acquired
  • Employee Count: 5,000 - 9,999 as on Mar 01, 2026
  • Investors: LH Ventures and Europa
  • Latest Funding Round: Grant (prize money), Oct 01, 2016, $*****
  • Highlight: Acquired

IPOs and Publicly Listed companies in LH Ventures' Portfolio

1 of LH Ventures' portfolio company became public -  Savara Pharma. It got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Apr 2017 at marketcap of undefined
Here are LH Ventures' portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Apr 27, 2017
-
-
7608

Acquired companies in LH Ventures' Portfolio

6 companies from LH Ventures' portfolio have been acquired. The most recent acquisition was C360 in Jan 2023 by Cosm for $*****.
Here are LH Ventures' portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Jan 11, 2023
-
-
3260
Jun 27, 2022
-
-
4839
Jan 28, 2019
-
-
2295
Sep 06, 2016
-
-
8760
Feb 10, 2015
-
-
1953

Team profile of LH Ventures

LH Ventures has a team of 1 member located in China. LH Ventures' team does not sit on the board of any company as of now.

Recent News related to LH Ventures

View all news related to LH Ventures

FAQs about LH Ventures

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford